Explore

Nationwide Recall Issued for Levothyroxine Sodium Tablets Due to Subpotency

Nationwide Recall Issued for Levothyroxine Sodium Tablets Due to Subpotency

Major Rugby, a pharmaceutical manufacturer, has issued a nationwide recall for several batches of levothyroxine sodium tablets, a common medication used to treat hypothyroidism and other thyroid-related conditions. The recall affects 12 packages of the medication, which were found to be subpotent, meaning they deliver less medication than intended. Despite the recall, Major Rugby has stated that taking the affected tablets is not likely to cause adverse health effects. The recall includes various dosages and lot numbers, and consumers are advised to return the medication to the point of purchase and consult their healthcare providers if they have the recalled product.

FDA Issues Recall for Levothyroxine Sodium Tablets Due to Subpotency

FDA Issues Recall for Levothyroxine Sodium Tablets Due to Subpotency

The Food and Drug Administration (FDA) has issued a Class II recall for levothyroxine sodium tablets, a medication commonly prescribed for hypothyroidism and reducing enlarged thyroid glands. The recall was announced on July 13 due to the tablets being subpotent, meaning they contain less of the active ingredient than required, making them less effective. Major Pharmaceuticals and Cardinal Health distributed the recalled tablets, which include twelve different dosages. The recall affects products distributed nationwide, although the FDA has not specified the number of tablets involved.

New Research Unveils How Brain Receptor Manipulation Aids Weight Loss

New Research Unveils How Brain Receptor Manipulation Aids Weight Loss

Researchers at the Institute of Metabolic Science, University of Cambridge, have discovered why both stimulating and blocking a specific brain receptor, GIPR, can aid in weight loss. Their study, conducted on mice, revealed that the location of the receptor in the brain determines its effect. Stimulating GIPR in the brainstem suppresses appetite, while blocking it in the hypothalamus achieves a similar outcome. This discovery could lead to the development of more effective obesity treatments. The study highlights the central role of the brain in obesity management, suggesting that obesity drugs impact specific brain circuits that regulate appetite and food intake.

FDA Recalls Levothyroxine Sodium Tablets Due to Subpotency Concerns

FDA Recalls Levothyroxine Sodium Tablets Due to Subpotency Concerns

The Food and Drug Administration (FDA) has issued a Class II recall for certain lots of levothyroxine sodium tablets distributed by Major Pharmaceuticals. The recall is due to the tablets being 'subpotent,' meaning they may not deliver the full prescribed dose. Levothyroxine sodium is commonly used to treat underactive thyroid and goiter. The affected lots include 10-count blister packs and 100-tablet cartons with dosages ranging from 25 micrograms to 150 micrograms. The expiration dates for these lots range from July 2026 to January 2027. Patients are advised to check their medication against the FDA's list of affected lot numbers and consult their healthcare provider if there is a match. The FDA assures that any health effects from the lower dose are expected to be temporary and reversible.

Study Links Sleep Deprivation to Weight Gain, Highlights Metabolic Risks

Study Links Sleep Deprivation to Weight Gain, Highlights Metabolic Risks

Study Links Sleep Deprivation to Weight Gain, Highlights Metabolic Risks

Why strawberries are one of the best fruits for health, weight loss

Why strawberries are one of the best fruits for health, weight loss

Strawberries pack an impressive amount of nutrition into every bite, with fiber being one of their standout nutrients.

Dexlansoprazole Use Requires Awareness of Drug Interactions and Lifestyle Factors

Dexlansoprazole Use Requires Awareness of Drug Interactions and Lifestyle Factors

Dexlansoprazole, a proton pump inhibitor, requires careful management due to potential drug interactions and lifestyle factors. The medication can interact with drugs like clopidogrel, reducing its antiplatelet effect and increasing clot risk. Patients are advised to avoid crushing or chewing the capsules to maintain the dual delayed-release mechanism. Alcohol and certain foods can undermine the medication's goals by irritating the esophageal lining. Patients with a history of Clostridioides difficile infection or liver impairment may require additional monitoring.

Research Highlights Role of Tertiary Lymphoid Structures in Periodontitis Progression

Research Highlights Role of Tertiary Lymphoid Structures in Periodontitis Progression

Recent research has identified the presence and maturation of tertiary lymphoid structures (TLS) in periodontitis tissues, which are linked to disease progression. Using multiplex immunohistochemistry, scientists observed that these structures, composed mainly of T helper (Th) cells and B cells, become more organized and mature as periodontitis advances. The study found that TLSs facilitate B cell maturation and are associated with poor surgical outcomes in periodontitis patients. The research also highlighted the role of CXCL13+ fibroblasts in TLS formation, suggesting that these cells may coordinate the assembly of TLSs in inflamed periodontal tissues.

Study Links Sleep Deprivation to Weight Gain in Adults

Study Links Sleep Deprivation to Weight Gain in Adults

A new study published in the Annals of Internal Medicine has found that adults who sleep 90 minutes less each night for six weeks gain approximately one pound on average compared to when they get adequate rest. Conducted by researchers at Columbia University Irving Medical Center, the study involved 95 adults at risk for heart or metabolic disease. Participants experienced weight gain and slightly larger waistlines during the sleep-restricted phase, although no significant changes in body fat or muscle mass were detected. The study highlights the role of sleep in regulating metabolism, with Dr. Somi Javaid, an Ohio-based OB-GYN, emphasizing the importance of sleep for metabolic health, particularly for women undergoing menopause.

Qarabağ University Clinic Advances Healthcare with Academic Integration

Qarabağ University Clinic Advances Healthcare with Academic Integration

Qarabağ University Clinic, established in 2025, is a modern healthcare center that integrates medical services with academic research. The clinic aims to provide high-quality medical care by combining clinical expertise, modern technologies, and evidence-based approaches. It collaborates closely with the School of Medicine and Health Sciences of Qarabağ University, creating an environment where education and clinical practice develop in tandem. This model not only enhances patient care but also contributes to the training of future healthcare professionals.

Medical Experts Highlight Persistent Gaps in Women's Health Research and Treatment

Medical Experts Highlight Persistent Gaps in Women's Health Research and Treatment

Recent discussions have brought to light significant gaps in women's health research and treatment, particularly concerning menopause and related conditions. Dr. Elizabeth Comen, a medical oncologist, emphasizes that despite advancements in medicine, there remain substantial deficiencies in addressing women's health comprehensively. Historically, women were underrepresented in clinical trials, and many aspects of women's health, such as neurological and cardiovascular care, remain under-researched. The lack of focus on women's health issues is partly attributed to societal and cultural factors that have historically limited women's agency over their bodies. This has resulted in a healthcare system that often fails to adequately address the unique health needs of women, leading to a reliance on non-evidence-based treatments and misinformation.

Breast Cancer Research Stamp Reauthorization Act Passes House

Breast Cancer Research Stamp Reauthorization Act Passes House

The Breast Cancer Research Stamp Reauthorization Act has been passed on the House floor as part of a larger legislative package. Since its inception in 1998, the stamp has raised nearly $100 million for breast cancer research. The act's passage is a significant step in continuing to fund research efforts aimed at combating breast cancer.